Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Jan 21;24(3):589-91.
doi: 10.1523/JNEUROSCI.4921-03.2004.

Reduced serotonin type 1A receptor binding in panic disorder

Affiliations
Clinical Trial

Reduced serotonin type 1A receptor binding in panic disorder

Alexander Neumeister et al. J Neurosci. .

Abstract

Recent animal models suggest that disturbances in serotonin type-1A receptor (5-HT(1A)R) function may contribute to chronic anxiety, although it is not clear at all whether such models constitute relevant models for panic disorder (PD) in humans. The selective 5-HT(1A)R radioligand [18F]trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (FCWAY) permits in vivo assessment of central 5-HT(1A)R binding using positron emission tomography (PET). We studied 16 unmedicated symptomatic outpatients with PD and 15 matched healthy controls. Seven patients had an additional diagnosis of a current major depressive episode, however PD was the primary diagnosis. A 120 min PET study of 5-HT(1A)R binding was acquired using a GE Advance scanner in three-dimensional mode. Using quantitative PET image analysis, regional values were obtained for [18F]-FCWAY volume of distribution (DV), corrected for plasma protein binding, and K1, the delivery rate of [18F]-FCWAY from plasma to tissue. MRI scanning was performed using a GE Signa Scanner (3.0 Tesla) to provide an anatomical framework for image analysis and partial volume correction of PET data. PD patients showed lower DV in the anterior cingulate (t = 4.3; p < 0.001), posterior cingulate (t = 4.1; p < 0.001), and raphe (t = 3.1; p = 0.004). Comparing patients with PD, patients with PD and comorbid depression, and healthy controls revealed that DVs did not differ between PD patients and PD patients with comorbid depression, whereas both patient groups differed significantly from controls. These results provide for the first time in vivo evidence for the involvement of 5-HT(1A)Rs in the pathophysiology of PD.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scatter histograms of the 5-HT1A receptor DV values for the panic disorder (PD) and control groups (▾). Within the PD sample, distinct symbols designate the pure PD (○) and the PD plus comorbid depression (•) subgroups. Mean (±SEM) bars indicate the significant differences between PD and controls groups, whereas no differences were found between the PD subgroup

References

    1. Bronen RA, Cheung G (1991) Relationship of hippocampus and amygdala to coronal MRI landmarks. Magn Reson Imaging 9: 449-457. - PubMed
    1. Carson RE, Lang L, Watabe H, Der MG, Adams HR, Jagoda E, Herscovitch P, Eckelman WC (2000) PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635. Nucl Med Biol 27: 493-497. - PubMed
    1. Charney DS, Drevets WC (2002) Neurobiological basis of anxiety disorders. In: Neuropsychopharmacology: the fifth generation of progress (Davis KL, Charney DS, Coyle JT, Nemeroff C, eds), pp 901-930. Philadelphia: Lippincott Williams and Wilkins.
    1. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375-1387. - PubMed
    1. First MB, Gibbon M, Spitzer RL, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders: nonpatient edition (SCID-I/NP). New York: Biometrics Department, New York State Psychiatric Institute.

Publication types

MeSH terms

Substances